GHRH 1-29
Also known as GHRH 1-29 — this name points to Sermorelin in our directory.
Also known as GHRH 1-29 — this name points to Sermorelin in our directory.
A GHRH analog that prompts the pituitary to release growth hormone—often stacked with GHRP peptides in clinic and research conversations.
Sermorelin mimics the first 29 amino acids of growth-hormone-releasing hormone. It stimulates pulsatile GH release rather than supplying GH directly. It was FDA-approved as a diagnostic (Geref) but is widely discussed off-label for anti-aging and recovery protocols. Human data for cosmetic or athletic use is limited.
GHRH 1-29 is a marketing or trade name people search when they mean Sermorelin. On retail shelves the INCI list on the back of the package may use a longer systematic name even when the front label shows a nickname.
Yes. GHRH 1-29 is a brand or nickname that refers to Sermorelin in our directory—the same active molecule, different packaging or marketing name.
A GHRH analog that prompts the pituitary to release growth hormone—often stacked with GHRP peptides in clinic and research conversations. Sermorelin mimics the first 29 amino acids of growth-hormone-releasing hormone. It stimulates pulsatile GH release rather than supplying GH directly. It was FDA-approved as a diagnostic (Geref) but is widely discussed off-label for anti-aging and recovery protocols. Human data for cosmetic or athletic use is limited.
GHRH 1-29 may appear on retail product fronts, but confirm the INCI list matches Sermorelin before assuming the formula is identical across brands.